Non-obstructive patterns of spirometry among obese patients presenting with symptoms and signs of mild to moderate asthma
DOI:
https://doi.org/10.52981/sjms.v7i3.823Keywords:
Obesity, Reversibility, FEV1, FVCAbstract
Background: Asthmatic patients typically show obstructive pattern on spirometry; with positive response to bronchodilators. However, there is paucity of data regarding presentation of obese patients with non-obstructive patterns of spirometry.
Methods: A sample of 295 known asthmatic patients (74% over-weights or obese and 26% nonobese) was selected from those attending respiratory clinic of Yastabshiron Hospital for follow up. A portable spirometer (All flow, Clement Clarke International, UK) was used for measurement of
FEV1, FVC, FEV1/FVC ratio and PEF for each patient. Measurements were carried out on presentation and then 15 minutes following inhalation of 0.5 mg salbutamol using a spacer.
Results: Typical obstructive pattern was found in only 17.4% of obese patients, normal pattern in 18.3%, restrictive in 45.9% and combined pattern in 18.3%. The relation between obesity and patterns of spirometry was found to be statistically insignificant (P= 0.808). Significant proportions
of all patterns showed positive reversibility tests (P= 0.000).
Conclusion: It is concluded that all patterns of spirometry are expected in obese patients with mild to moderate asthma. Reversibility tests are highly significant among asthmatic patients, irrespective to their spirometric pattern.
References
2. British Thoracic Society/Scottish Intercollegiate Guidelines Network. Guidelines on Asthma Management (May 2008)
3. British Thoracic Society/ COPD Consortium.Spirometry in practice: a practical guide to using spirometry in primary care. 2nd ed. April 2005.
4. Barreiro TJ, Perillo I. An approach to interpreting spirometry. Am Fam Physician 2004;69(5):1107- 1115.
5. Pellegrino R, Viegi G, Brusasco V, et al. Interpretive strategies for lung function tests. Eur Respir J 2005;26:948-68.
6. Baumann UA, Haerdi E, Keller R. Relations between clinical signs and lung function in bronchial asthma: How is acute bronchial obstruction reflected in dyspnea and wheezing Respiration 1986;50:294–300.
7. O'Connell E, Rojas AR, Sachs MI. Cough-type asthma: a review. Ann Allergy 1991;66:278–286.
8. Flenley DC. Chronic obstructive pulmonary disease. Dis Mon 1988;34:537-599.
9. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
10. World Medical Association Medical EthicsCommittee. Updating the WMA Declaration of Helsinki. Wld Med J 1999; 45:11-13
11. Nair SJ, Daigle KL, DeCuir P, Lapin. CD,Schramm CM. The influence of pulmonary function testing on the management of asthma in children. J Pediatr 2005;147(6):797-801.
12. Holleman DR Jr, Simel DL. Does the clinical examination predict airflow limitation? JAMA1995;273:313–9.
13. Cowen MK, Wakefield, DB, Cloutier MM.Classifying asthma severity: objective versus subjective measures. J Asthma. 2007; 44(9): 711- 715.
14. Bonner JR. The epidemiology and natural history of asthma. Clin Chest Med 1984;5:557-65.
15. Martin AJ, McLennan LA, Landau LI, Phelan PD. The natural history of childhood asthma to adult life. Br Med J 1980;280:1397-400.
16. Schatz M, Clark S, Camargo CA Jr. Sex differences in the presentation and course of asthma hospitalizations. Chest. 2006 Jan;129(1):50-5.
17. Baibergenova A, Thabane L, Akhtar-Danesh N,Levine M, Gafni A. Patient characteristics associated with nocturnal emergency department visits for asthma. J Asthma. 2006 Aug;43(6):469-75.
18. Temprano J, Mannino DM. The effect of sex on asthma control from the National Asthma Survey. J Allergy Clin Immunol. 2009;123:854–60.
19. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157(1):123–128.
20. Lima JJ, Mohamed MH, Self TH, Eberle LV,Johnson JA. Importance of beta(2)adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics.Pulm Pharmacol Ther. 2000;13:127-134.
21. Birnbaum S, Barreiro TJ. Methacholine Challenge Testing: Identifying its Diagnostic Role, Testing,Coding, and Reimbursement. CHEST2007;131(6):1932-1935.